Certolizumab pegol induced paradoxical psoriatic alopecia with therapeutic response to bimekizumab. [PDF]
Taş Aygar G +4 more
europepmc +1 more source
Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE). [PDF]
Vladimirova N +11 more
europepmc +1 more source
Current status and emerging trends in biological therapies for ankylosing spondylitis: A bibliometric analysis (2004-2024). [PDF]
Deng R +5 more
europepmc +1 more source
Clinical Characteristics and a New Classification System of Mono-Segmental Thoracic and Lumbar Nonfusion in Patients With Ankylosing Spondylitis. [PDF]
Liu B, Wang Z, Zhou F, Tian Y, Zhang Z.
europepmc +1 more source
Short-form video platforms as a source of ankylosing spondylitis information: a cross-sectional content analysis. [PDF]
Wei X +5 more
europepmc +1 more source
Association between 1400 blood metabolites and the risk of ankylosing spondylitis: A 2-stage, 2-sample Mendelian randomization study. [PDF]
Li F, Zhou X, Li C, Zhang Z, Yang Q.
europepmc +1 more source
Use of O-arm navigation in percutaneous pedicle screw fixation for thoracolumbar fractures in patients with ankylosing spinal disorders: reducing intraoperative radiation exposure-a retrospective cohort study. [PDF]
Kumagai G +5 more
europepmc +1 more source
Relationship between ultrasound damage score of peripheral entheses and spinal bone formation in long-standing radiographic axial spondyloarthritis. [PDF]
Deminger A +4 more
europepmc +1 more source
Psychometric validation of the Bulgarian Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire: linking quality of life with disease activity in axial spondyloarthritis. [PDF]
Pencheva DT +5 more
europepmc +1 more source

